Citagenix Regen LLC

Citagenix, operating as the US division of HANSAmed Limited since 1997, is a global supplier of regenerative biomaterials for dental, periodontal, implant, and orthopedic applications. The company manufactures and distributes a comprehensive portfolio of allograft-based bone grafts, barrier membranes, matrices, and biologics for guided bone regeneration (GBR), guided tissue regeneration (GTR), ridge preservation, and socket grafting. Core product lines include Raptos® demineralized bone matrix (DBM) putties and particulates (100% human allograft), ProtFactor™ lyophilized allograft-derived protein supplements enriched with naturally occurring growth factors, CevOss™ deproteinized bovine bone, Neomem® resorbable collagen membranes (derived from porcine peritoneum and amnion-chorion), and specialized wound dressings (NeoPlug™, NeoCote™, NeoTape™). The company also supplies surgical essentials including bone and membrane fixation devices, specialized instruments, and regenerative accessories. Products are marketed to dental surgeons, periodontists, implant dentists, and oral surgeons primarily through an extensive North American distributor network including major dental supply chains (BencoDental, Burkhart, Darby, Frontier). Citagenix emphasizes clinical evidence, handling characteristics, and osteoinductive/osteogenic potential in regenerative applications. The company maintains direct sales support and operates an AI-assisted product information chat system.